Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 680, Issue 1-2, 2009, Pages 56-63

  Gangwar, Ruchika ^a   Ahirwar, Dinesh ^a   Mandhani, Anil ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

BCG immunotherapy; DNA repair; Polymorphism; Recurrence; Urothelial bladder cancer

Indexed keywords

ADULT; ALLELE; ARTICLE; BLADDER CANCER; CANCER GENETICS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; DNA REPAIR; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; OGG1 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; XRCC3 GENE; XRCC7 GENE;

ADENOCARCINOMA; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 72149114321     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.09.008     Document Type: Article

References (35)

1. van Gent D.C., Hoeijmakers J.H., and Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet. 2 (2001) 196-206
2. Berwick M., and Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl. Cancer Inst. 92 (2000) 874-897
3. Vodicka P., Kumar R., Stetina R., Sanyal S., Soucek P., Haufroid V., Dusinska M., Kuricova M., Zamecnikova M., Musak L., Buchancova J., Norppa H., Hirvonen A., VodickovaL, Naccarati A., Matousu Z., and Hemminki K. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rate, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 25 (2004) 757-763
4. A.S. Ibrahim H.M. Khaled, Urinary bladder cancer, MECC Monograph Chapter 11, pp.97-110
5. Shinmura K., and Yokota J. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid. Redox Signal 3 (2001) 597-609
6. Kohno T., Shinmura K., Tosaka M., Tani M., Kim S.R., Sugimura H., Nohmi T., Kasai H., and Yokota J. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged NA. Oncogene 16 (1998) 3219-3225
7. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1513-1530
8. Manuguerra M., Saletta F., Karagas M.R., Berwick M., Veglia F., Vineis P., and Matullo G. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer. Am. J. Epidemiol. 164 (2006) 297-302
9. Synowiec E., Stefanska J., Morawiec Z., Blasiak J., and Wozniak K. Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat Res. 648 (2008) 65-72
10. Khanna K.K., and Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 3 (2001) 247-254
11. Wang L.E., Bondy M.L., Shen H., El-Zein R., Aldape K., Cao Y., Pudavalli V., Levin V.A., Yung W.K., and Wei Q. Polymorphisms of DNA repair genes and risk of glioma. Cancer Res. 64 (2004) 5560-5563
12. Bevers R.F.M., Kurth K.H., and Schamhart D.H.J. Role of urothelial cells in BCG immunotherapy for superficial bladder cancer. Br. J. Cancer 91 (2004) 607-612
13. Colombel M., Soloway M., and Akaza H. Epidemiology, staging, grading and risk stratification of bladder cancer. Eur. Urol. Suppl. 7 (2008) 618-626
14. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215
15. Le Marchand L., Donlon T., Lum-Jones A., Seifried A., and Wilkens L.R. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 409-412
16. López-Cima M.F., González-Arriaga P., García-Castro L., Pascual T., Marrón M.G., Puente X.S., and Tardón A. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer 16 (2007) 162
17. Wang S.Y., Peng L., Li C.P., Li A.P., Zhou J.W., Zhang Z.D., and Liu Q.Z. Genetic variants of the XRCC7 gene involved in DNA repair and risk of human bladder cancer. Int. J. Urol. 15 (2008) 534-539
18. Wang J., and Shete S. A test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in cases. Am. J. Hum. Genet. 83 (2008) 53-63
19. Larsson P., Wijkstrom H., Thorstenson A., et al. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand J. Urol. Nephrol. 37 (2003) 195-201
20. Hayden P.J., Tewari P., Morris D.W., et al. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma. Hum. Mol. Genet. 16 (2007) 3117-3127
21. Yamane A., Kohno T., Ito K., et al. Differential ability of polymorphicOGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis 25 (2004) 1689-1694
22. Arizono K., Osada Y., and Kuroda Y. DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn. J. Clin. Oncol. 38 (2008) 186-191
23. Li H., Hao X., Zhang W., Wei Q., and Chen K. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 1739-1745
24. Sakamoto T., Higaki Y., Hara M., Ichiba M., Horita M., Mizuta T., Eguchi Y., Yasutake T., Ozaki I., Yamamoto K., Onohara S., Kawazoe S., Shigematsu H., Koizumi S., and Tanaka K. hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among Japanese. J. Epidemiol. 16 (2006) 233-239
25. Lindh A.R., Rafii S., Schultz N., Cox A., and Helleday T. Mitotic defects in XRCC3 variantsT241M and D213N and their relation to cancer susceptibility. Hum. Mol. Genet. 15 (2006) 1217-1224
26. Shen M., Hung R.J., Brennan P., Malaveille C., Donato F., Placidi D., Carta A., Hautefeuille A., Boffetta P., and Porru S. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 1234-1240
27. Han S., Zhang H.T., Wang Z., Xie Y., Tang R., Mao Y., and Li Y. DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Eur. J. Hum. Genet. 14 (2006) 1136-1144
28. Hopfner K.P., Putnam C.D., and Tainer J.A. DNA double-strand break repair from head to tail. Curr. Opin. Struct. Biol. 12 (2002) 115-122
29. Stronati L., Gensabella G., Lamberti C., et al. Expression and DNA binding activity of the Ku heterodimer in bladder carcinoma. Cancer 92 (2001) 2484-2492
30. Sturgis E.M., Clayman G.L., Guan Y., et al. DNA repair in lymphoblastoid cell lines from patients with head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 125 (1999) 185-190
31. Hirata H., Hinoda Y., Tanaka Y., Okayama N., Suehiro Y., Kawamoto K., Kikuno N., Majid S., Vejdani K., and Dahiya R. Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur. J. Cancer 43 (2007) 231-237
32. Hirata H., Hinoda Y., Matsuyama H., Tanaka Y., Okayama N., Suehiro Y., Zhao H., Urakami S., Kawamoto K., Kawakami T., Igawa M., Naito K., and Dahiya R. Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Biochem. Biophys. Res. Commun. 342 (2006) 1058-1062
33. Sipley J.D., Menninger J.C., Hartley K.O., Ward D.C., Jackson S.P., and Anderson C.W. Gene for the catalytic subunit of the human DNA-activated protein kinase maps to the site of the XRCC7 gene on chromosome 8. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7515-7519
34. Johansson S.L., and Cohen S.M. Epidemiology and etiology of bladder cancer. Semin. Surg. Oncol. 13 (1997) 291-298
35. Sanyal S., De Verdier P.J., Steineck G., Larsson P., Onelöv E., Hemminki K., and Kumar R. Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms. Acta Oncol. 46 (2007) 31-41